Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
N. Lynn Henry(University of Michigan), Vered Stearns(Johns Hopkins University), Todd C. Skaar(Indiana University School of Medicine), Jessica Dantzer(University School), Anne Nguyen(Indiana University School of Medicine), James M. Rae(University of Michigan), Daniel F. Hayes(University of Michigan–Ann Arbor), Mark A. Helvie(Dartmouth–Hitchcock Medical Center), Linze Li(Pacific Northwest National Laboratory), Santosh Philips(Indiana University School of Medicine), Lubomir M. Hadjiiski(University of Michigan), Zeruesenay Desta(Indiana University School of Medicine), Chuan Zhou(University of Michigan), Chirayu Goswami(Thomas Jefferson University Hospital), David A. Flockhart(Indiana University – Purdue University Indianapolis), Renee W. Pinsky(University of Michigan), Nagi F. Khouri(Johns Hopkins University), Steffi Oesterreich(University of Pittsburgh), A. M. Storniolo(University School), Jason Robarge(Washington University in St. Louis)
Cited by 29
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k